Stock Watch: Funding Biotech In A Hostile Environment
All-Stock Mergers On The Up As Financing Options Dwindle
When the traditional fundraising window closes and clinical, regulatory or commercial success eludes, other routes to raise cash emerge. But these have also become more scarce recently, leaving all-stock consolidations.
